Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3843751 Title: PRODUIT ASSOCIANT UN INHIBITEUR DE BCL-2/BCL-XL ET UN AGENT CHIMIOTHÉRAPEUTIQUE, ET UTILISATION ASSOCIÉE DANS LA PRÉVENTION ET/OU LE TRAITEMENT DE MALADIES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
208477778
WO application number:
CN2020105810
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3843751
WO publication number:
WO2021018240
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
30/07/2020
Grant date:
27/03/2024
EP publication date:
07/07/2021
WO publication date:
04/02/2021
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
27/03/2024
EP B1 publication date:
27/03/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/07/2024
Expiration date (if granted and all annual fees paid):
30/07/2040

Applicant

1

Name:
Ascentage Pharma (Suzhou) Co., Ltd.
Legal Form:
From:
27/03/2024
Address:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, China (CN)
To:

2

Name:
Ascentage Pharma Group Corp Limited
Legal Form:
From:
27/03/2024
Address:
9/F, Wah Yuen Building 149 Queen's Road Central, Hong Kong, Hong Kong (HK)
To:

Inventor

1

Name:
YANG, Dajun
Legal Form:
Address:
Suzhou, Jiangsu 215000, China (CN)

2

Name:
ZHAI, Yifan
Legal Form:
Address:
Suzhou, Jiangsu 215000, China (CN)

3

Name:
FANG, Douglas Dong
Legal Form:
Address:
Suzhou, Jiangsu 215000, China (CN)

4

Name:
TANG, Qiuqiong
Legal Form:
Address:
Suzhou, Jiangsu 215000, China (CN)

Priority

1

Priority patent number:
202010631089
Priority date:
03/07/2020
Priority country:
China (CN)

2

Priority patent number:
PCT/CN2019/098625
Priority date:
31/07/2019
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
A61K 31/496; A61K 31/55; A61P 35/00; A61P 35/02; A61P 35/04;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2024/06
Publication date:
04/04/2024
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202413
Publication date:
27/03/2024
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type